Compass trial

Research status

In progress

Overview of Study

On 1 December 2017, the National Cervical Screening Program introduced new recommendations for cervical screening – asymptomatic women aged 25 to 74 years should have a Cervical Screening Test (CST) every 5 years.


The Compass trial is a randomized controlled trial which aims to compare 2.5 year cytology screening (Pap smear) with the 5 yearly HPV screening.

Over 76,000 women were recruited to this study. Family Planning NSW were one of the may recruiting sites across Australia, and supported recruitment of women aged 25-38 years to participate.  Recruitment for the study has now closed. All participants will be actively followed for up to 5 years from the time of their recruitment.

This trial is being conducted by VCS Foundation and Cancer Council Australia. This study has been reviewed and approved by the Family Planning NSW Ethics Committee.


VCS Foundation and Cancer Council Australia

Contact Details

For more information about the Compass trial, please visit or email

Share this page:

Find health


Request an



a course

Resources in

your language

Call or email Talkline